05/10/2024
9:37 AM | Kiromic BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:29 PM | Kiromic BioPharma (Issuer)
Mirandola Leonardo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
4:00 PM | BERSANI PIETRO (Filed by)
Kiromic BioPharma (Subject)
| Form SC 13D/A | |
05/07/2024
5:17 PM | Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:30 PM | Kiromic BioPharma (Filer)
| Form PRE 14A | |
05/07/2024
4:00 PM | BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/19/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form RW | |
04/05/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
4:21 PM | Kiromic BioPharma (Filer)
| Form 10-K/A | |
03/20/2024
4:58 PM | Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:55 PM | Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:57 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
8:56 PM | Kiromic BioPharma (Subject)
YA II PN, Ltd. (Filed by)
| Form SC 13G/A | |
01/11/2024
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
9:25 AM | Empery Asset Management, LP (Filed by)
Kiromic BioPharma (Subject)
| Form SC 13G/A | |
11/20/2023
7:46 AM | Kiromic BioPharma (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
11/09/2023
8:49 AM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
3:30 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
3:05 PM | Hungerford Brian (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:06 PM | Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:07 PM | Kiromic BioPharma (Issuer)
NAGEL MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:07 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
3:08 PM | BERSANI PIETRO (Reporting)
Kiromic BioPharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:05 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
3:45 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
3:52 PM | Kiromic BioPharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023
11:28 AM | Catlin Michael (Reporting)
Kiromic BioPharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2023
5:31 PM | Kiromic BioPharma (Issuer)
Misajon Pamela (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2023
2:53 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:21 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
3:22 PM | Kiromic BioPharma (Filer)
| Form DEFA14A | |
06/29/2023
3:33 PM | Kiromic BioPharma (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/27/2023
3:15 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:23 PM | Kiromic BioPharma (Filer)
| Form DEF 14A | |
06/12/2023
3:22 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
3:16 PM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
05/22/2023
9:31 AM | Kiromic BioPharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2023
11:15 PM | Kiromic BioPharma (Filer)
| Form EFFECT | |
05/19/2023
3:49 PM | Kiromic BioPharma (Filer)
| Form 424B3 | |
